S. Hara et al., INVOLVEMENT OF NITRIC-OXIDE IN INTRACEREBROVENTRICULAR BETA-ENDORPHIN-INDUCED NEURONAL RELEASE OF METHIONINE-ENKEPHALIN, Brain research, 675(1-2), 1995, pp. 190-194
Previous work has suggested that the antinociceptive effect of nitrous
oxide (N2O) in rats is mediated, at least in part, by beta-endorphin
(beta-EP) and that centrally administered beta-EP stimulates release o
f methionine-enkephalin (ME) in the rat spinal cord. Since inhibition
of central nitric oxide (NO) production has been found to suppress N2O
antinociception, we examined the possible involvement of NO in the re
lease of spinal cord ME by i.c.v. beta-EP. Urethane-anesthetized, male
Sprague-Dawley rats were intrathecally (i.t.) perfused with artificia
l cerebrospinal fluid (aCSF) and fractions of perfusate were assayed f
or immunoreactive (i.r.) ME. The beta-EP-induced increase in ME concen
tration in the i.t. perfusate was significantly suppressed by perfusin
g the animal with aCSF containing 100 mu M L-N-G-nitro arginine (L-NOA
RG), an inhibitor of NO synthase (NOS). The further addition of 50 mu
M L-arginine (L-ARG), but not D-arginine (D-ARG), to the aCSF reversed
the suppression of the ME change by L-NOARG. However, the potency of
L-ARG decreased with increasing concentrations of L-ARG. On the other
hand, increasing the concentration of L-NOARG in the aCSF to 250 mu M
failed to produce a greater suppression of the beta-EP-induced increas
e in ME. These findings suggest that NO may mediate the beta-EP-induce
d release of ME in the spinal cord and that interference with this mec
hanism might be an explanation for the antagonism of N2O antinocicepti
on in rats by NOS inhibitors.